Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Enitociclib by Vincerx Pharma for Non-Hodgkin Lymphoma: Likelihood of Approval
Enitociclib is under clinical development by Vincerx Pharma and currently in Phase I for Non-Hodgkin Lymphoma. According to GlobalData, Phase...
Data Insights
Enitociclib by Vincerx Pharma for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
Enitociclib is under clinical development by Vincerx Pharma and currently in Phase II for Diffuse Large B-Cell Lymphoma. According to...